MiNK TherapeuticsOrganizationRORGet new research by emailTrialsA Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory FailurePhase 2, Recruiting, 90 people, May 29, 2026Sources: clinicaltrials.gov